Condensed Consolidated Statements Of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 832.2	$ 756.3
Loss from discontinued operations	1.7	2.5
Earnings from continuing operations	833.9	758.8
Adjustments to reconcile earnings from continuing operations to net cash from operations:
Depreciation and amortization	239.3	239.2
Gain on sale of investment in CareFusion	0	(71.5)
Impairments and loss on disposal of assets	19.4	8.2
Share-based compensation	63.1	60.4
Provision for bad debts	6.7	22.2
Change in fair value of contingent consideration obligation	(53.2)	(0.4)
Change in operating assets and liabilities, net of effects from acquisitions:
Increase in trade receivables	(310.5)	(578.9)
Increase in inventories	(869.9)	(1,048.1)
Increase in accounts payable	1,212.2	1,986.4
Other accrued liabilities and operating items, net	141.9	(101.0)
Net cash provided by operating activities-continuing operations	1,282.9	1,275.3
Net cash used in operating activities-discontinued operations	0	(0.5)
Net cash provided by operating activities	1,282.9	1,274.8
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of subsidiaries, net of cash acquired	(142.6)	(2,295.0)
Purchase of held-to-maturity securities and other investments	(10.5)	(155.6)
Additions to property and equipment	(159.0)	(183.1)
Proceeds from sale of investment in CareFusion	0	705.9
Proceeds from maturities of held-to-maturity securities	46.0	0
Net cash used in investing activities	(266.1)	(1,927.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net change in short-term borrowings	8.2	41.5
Reduction of long-term obligations	(44.5)	(228.1)
Proceeds from long-term obligations, net of issuance costs	0	494.5
Proceeds from issuance of Common Shares	22.9	36.0
Tax proceeds/(disbursements) from exercises of stock options	3.6	(8.7)
Dividends on Common Shares	(225.9)	(205.9)
Purchase of treasury shares	(300.0)	(269.8)
Net cash used in financing activities	(535.7)	(140.5)
NET INCREASE/(DECREASE) IN CASH AND EQUIVALENTS	481.1	(793.5)
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD	1,929.3	2,755.3
CASH AND EQUIVALENTS AT END OF PERIOD	$ 2,410.4	$ 1,961.8